eCardio Merges with Preventice
September 10th, 2014
Ambulatory cardiac monitoring service company eCardio announced that it has formalized an agreement to merge with remote monitoring device company called Preventice. This merger is comes just a few weeks after eCardio was acquired by Merck, which the Merck Global Innovation Fund is a major stakeholder in Preventice funding their development of their peel & stick remote monitoring technology. The new company will be called Preventice operating in the Houston based facilies of eCardio.
The merger is set to increase access of the Preventice product line with eCardio’s customer base for ambulatory cardiac monitoring services. The Preventice BodyGaurdian RMS cardiac monitor detects cardiac abnormalities for patients in the ambulatory setting. The device uses an algorithm that detects cardiac arrhythmias via wireless sensor to a dedicated smartphone where the information can be transmitted to an external laboratory for analysis. The BodyGuardian has FDA approval and was officially launched in 2013.